Related content

Biosimilars: The ‘future’ of biologic therapy?

By Ranjan Nitin   Mahajan Vikram K   Misra Monika  

Journal of Dermatological Treatment, Vol. 22, Iss. 6, 2011-12 ,pp. : 319-322

Informa Healthcare

Access to resources Recommend Favorite

Serum Infliximab Concentrations in Psoriatic Patients Treated with Infliximab: A Systematic Review

By Dannepond Carole   Maruani Annabel   Machet Laurent   Ternant David   Paintaud Gilles   Samimi Mahtab  

Acta Dermato-Venereologica, Vol. 95, Iss. 4, 2015-04 ,pp. : 401-406

Medical Journals Limited

Access to resources Recommend Favorite

Treatment of Pre-ulcerative Necrobiosis Lipoidica with Infliximab

By Conte Héléne   Milpied Brigitte   Kaloga Mamadou   Lalanne Nathalie   Belin Emilie   Jouary Thomas   Taïeb Alain   Ezzedine Khaled  

Acta Dermato-Venereologica, Vol. 91, Iss. 5, 2011-09 ,pp. : 587-588

Medical Journals Limited

Access to resources Recommend Favorite

Septic Shock after Treatment of Pyoderma Gangrenosum with Infliximab

By Wölbing Florian   Fierlbeck Gerhard   Hötzenecker Wolfram   Schaller Martin   Röcken Martin  

Acta Dermato-Venereologica, Vol. 89, Iss. 1, 2009-01 ,pp. : 93-94

Medical Journals Limited

Access to resources Recommend Favorite

Long-term efficacy of infliximab in hidradenitis suppurativa

By Paradela Sabela   Rodríguez-Lojo Romina   Fernández-Torres Rosa   Arévalo Pilar   Fonseca Eduardo  

Journal of Dermatological Treatment, Vol. 23, Iss. 4, 2012-08 ,pp. : 278-283

Informa Healthcare

Access to resources Recommend Favorite